Michael Mulroy is a Senior Advisor to CamberView Partners.
Mr. Mulroy is a former Executive Vice President of Questcor Pharmaceuticals, Inc. During his career at Questcor, he served in several roles, including Executive Vice President – Strategic Affairs, Chief Financial Officer and General Counsel, worked closely on corporate governance matters with the Nominating and Corporate Governance Committee of Questcor’s Board of Directors and played a key role in the company’s investor relations activities.
At Questcor, Mr. Mulroy was integral in the company’s defense against a multi-year, multi-activist short campaign. This campaign became public in January 2012, and continued until the sale of Questcor to Mallinckrodt plc in August 2014. During this period, Questcor successfully navigated many challenges, ultimately increasing the market price of the company’s stock more than five-fold from its low shortly after the activist campaign was launched until Questcor was acquired.
Prior to joining Questcor, Mr. Mulroy served as the company’s outside counsel. Earlier in his career, he worked as an investment banker at Citigroup and Merrill Lynch.
He currently serves on the Board of Directors of BioTime, Inc., a regenerative medicine company.
Mr. Mulroy holds a J.D. from the University of California, Los Angeles, and a bachelor’s degree from the University of Chicago.